| Year |
Citation |
Score |
| 2020 |
Khanna R, Ma C, Jairath V, Casteele NV, Zou G, Feagan BG. Endoscopic Assessment of Inflammatory Bowel Disease Activity in Clinical Trials. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 33338657 DOI: 10.1016/j.cgh.2020.12.017 |
0.342 |
|
| 2020 |
Dulai PS, Jairath V, Zou G, Stitt LW, Khanna R, Sandborn WJ, Feagan BG, Singh S. Early Combined Immunosuppression May Be More Effective for Reducing Complications in Isolated Colonic- vs Ileal-Dominant Crohn Disease. Inflammatory Bowel Diseases. PMID 32592481 DOI: 10.1093/Ibd/Izaa168 |
0.373 |
|
| 2020 |
Linggi B, Jaraith V, Zou G, Shackelton L, Feagan BG, Casteele NV. Mo1123 META-ANALYSIS OF GENE EXPRESSION DISEASE SIGNATURES IN COLONIC BIOPSY TISSUE FROM PATIENTS WITH ULCERATIVE COLITIS REDUCES RISK OF TYPE-1 ERROR AND ALLOWS FOR HARMONIZATION ACROSS STUDIES Gastroenterology. 158: S-796. DOI: 10.1016/S0016-5085(20)32664-0 |
0.304 |
|
| 2019 |
Ma C, Gecse KB, Duijvestein M, Sandborn WJ, Zou G, Shackleton LM, Stitt LW, Parker CE, Bossuyt P, Löwenberg M, Khanna R, Vermeire S, Rutgeerts P, Feagan BG, Jairath V, et al. Reliability of Endoscopic Evaluation of Postoperative Recurrent Crohn's Disease. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 31473359 DOI: 10.1016/J.Cgh.2019.08.046 |
0.367 |
|
| 2019 |
Duijvestein M, Jeyarajah J, Guizzetti L, Zou G, Parker CE, van Viegen T, VandeCasteele N, Khanna R, Van Der Aa A, Sandborn WJ, Feagan BG, D'Haens GR, Jairath V. Response to Placebo, Measured by Endoscopic Evaluation of Crohn's Disease Activity, in a Pooled Analysis of Data from 5 Randomized Controlled Induction Trials. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 31442599 DOI: 10.1016/J.Cgh.2019.08.025 |
0.403 |
|
| 2019 |
Hindryckx P, Jairath V, Zou G, Feagan BG, Sandborn WJ, Stoker J, Khanna R, Stitt L, van Viegen T, Shackelton LM, Taylor SA, Santillan C, Mearadji B, D'Haens G, Richard MP, et al. Development and Validation a Magnetic Resonance Index for Assessing Fistulas in Patients With Crohn's Disease. Gastroenterology. PMID 31336124 DOI: 10.1053/J.Gastro.2019.07.027 |
0.335 |
|
| 2019 |
Novak G, Stevens T, Van Viegen T, Bossuyt P, Štabuc B, Jeyarajah J, Zou G, Gaemers IC, McKee TD, Fu F, Shackelton LM, Khanna R, van den Brink GR, Sandborn WJ, Feagan BG, et al. Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn's disease. Alimentary Pharmacology & Therapeutics. PMID 30983024 DOI: 10.1111/Apt.15250 |
0.384 |
|
| 2019 |
Singh S, Stitt LW, Zou G, Khanna R, Dulai PS, Sandborn WJ, Feagan BG, Jairath V. Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT. Alimentary Pharmacology & Therapeutics. PMID 30891808 DOI: 10.1111/Apt.15214 |
0.367 |
|
| 2019 |
Dulai PS, Jairath V, Zou G, Stitt L, Khanna R, Sandborn WJ, Feagan BG, Singh S. Sa1814 – Early Combined Immunosuppression is More Effective for Reducing Crohn's Disease Related Complications in Isolated Colonic Than Ileal Dominant Crohn's: Post-Hoc Analysis of React Trial Gastroenterology. 156: S-412. DOI: 10.1016/S0016-5085(19)37881-3 |
0.382 |
|
| 2019 |
Singh S, Stitt L, Zou G, Khanna R, Dulai PS, Sandborn WJ, Feagan BG, Jairath V. 209 – Early Combined Immunosuppression is Effective and Safe in Older Patients with Crohn's Disease: Post-Hoc Analysis of React Cluster Randomized Trial Gastroenterology. 156: S-43-S-44. DOI: 10.1016/S0016-5085(19)36890-8 |
0.391 |
|
| 2018 |
Jairath V, Jeyarajah J, Zou G, Parker CE, Olson A, Khanna R, D'Haens GR, Sandborn WJ, Feagan BG. A composite disease activity index for early drug development in ulcerative colitis: development and validation of the UC-100 score. The Lancet. Gastroenterology & Hepatology. PMID 30343116 DOI: 10.1016/S2468-1253(18)30306-6 |
0.355 |
|
| 2018 |
Jairath V, Peyrin-Biroulet L, Zou G, Mosli M, Vande Casteele N, Pai RK, Valasek MA, Marchal-Bressenot A, Stitt LW, Shackelton LM, Khanna R, D'Haens GR, Sandborn WJ, Olson A, Feagan BG, et al. Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial. Gut. PMID 30076171 DOI: 10.1136/Gutjnl-2018-316702 |
0.404 |
|
| 2018 |
Khanna R, Zou G, Feagan BG. Evolution of the Randomized Controlled Trial in Inflammatory Bowel Disease: Current Challenges and Future Solutions. Inflammatory Bowel Diseases. PMID 29788218 DOI: 10.1093/Ibd/Izy117 |
0.347 |
|
| 2018 |
Samaan MA, Shen B, Mosli MH, Zou G, Sandborn WJ, Shackelton LM, Nelson S, Stitt L, Bloom S, Pardi DS, Gionchetti P, Lindsay J, Travis S, Hart A, Silverberg MS, et al. Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis. Gastrointestinal Endoscopy. PMID 29660321 DOI: 10.1016/J.Gie.2018.04.2330 |
0.386 |
|
| 2018 |
Warners MJ, Ambarus CA, Bredenoord AJ, Verheij J, Lauwers GY, Walsh JC, Katzka DA, Nelson S, van Viegen T, Furuta GT, Gupta SK, Stitt L, Zou G, Parker CE, Shackelton LM, et al. Reliability of histologic assessment in patients with eosinophilic oesophagitis. Alimentary Pharmacology & Therapeutics. PMID 29460418 DOI: 10.1111/Apt.14559 |
0.305 |
|
| 2018 |
Jairath V, Ordas I, Zou G, Panes J, Stoker J, Taylor SA, Santillan C, Horsthuis K, Samaan MA, Shackelton LM, Stitt LW, Hindryckx P, Khanna R, Sandborn WJ, D'Haens G, et al. Reliability of Measuring Ileo-Colonic Disease Activity in Crohn's Disease by Magnetic Resonance Enterography. Inflammatory Bowel Diseases. 24: 440-449. PMID 29361096 DOI: 10.1093/Ibd/Izx040 |
0.344 |
|
| 2017 |
Guizzetti L, Zou G, Khanna R, Dulai PS, Sandborn WJ, Jairath V, Feagan BG. Development of Clinical Prediction Models for Surgery and Complications in Crohn's Disease. Journal of Crohn's & Colitis. PMID 29028958 DOI: 10.1093/Ecco-Jcc/Jjx130 |
0.363 |
|
| 2017 |
Yan BM, Feagan B, Teriaky A, Mosli M, Mohamed R, Williams GS, Yeung E, Yong E, Haig A, Sey M, Stitt L, Zou GY, Jairath V. Reliability of EUS indices to detect inflammation in ulcerative colitis. Gastrointestinal Endoscopy. PMID 28760533 DOI: 10.1016/J.Gie.2017.07.035 |
0.309 |
|
| 2017 |
Mosli MH, Parker CE, Nelson SA, Baker KA, MacDonald JK, Zou GY, Feagan BG, Khanna R, Levesque BG, Jairath V. Histologic scoring indices for evaluation of disease activity in ulcerative colitis. The Cochrane Database of Systematic Reviews. 5: CD011256. PMID 28542712 DOI: 10.1002/14651858.Cd011256.Pub2 |
0.389 |
|
| 2017 |
Khanna R, Zou G, Stitt L, Feagan BG, Sandborn WJ, Rutgeerts P, McDonald JWD, Dubcenco E, Fogel R, Panaccione R, Jairath V, Nelson S, Shackelton LM, Huang B, Zhou Q, et al. Corrigendum: Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease. The American Journal of Gastroenterology. PMID 28417993 DOI: 10.1038/Ajg.2017.120 |
0.373 |
|
| 2017 |
Jairath V, Zou G, Parker CE, MacDonald JK, Mosli MH, AlAmeel T, Al Beshir M, AlMadi M, Al-Taweel T, Atkinson NS, Biswas S, Chapman TP, Dulai PS, Glaire MA, Hoekman D, et al. Systematic review with meta-analysis: placebo rates in induction and maintenance trials of Crohn's disease. Alimentary Pharmacology & Therapeutics. PMID 28164348 DOI: 10.1111/Apt.13973 |
0.365 |
|
| 2017 |
Khanna R, Zou G, Stitt L, Feagan BG, Sandborn WJ, Rutgeerts P, McDonald JW, Dubcenco E, Fogel R, Panaccione R, Jairath V, Nelson S, Shackelton LM, Huang B, Zhou Q, et al. Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease. The American Journal of Gastroenterology. PMID 28071654 DOI: 10.1038/Ajg.2016.580 |
0.405 |
|
| 2017 |
Jairath V, Zou G, Parker CE, MacDonald JK, Mosli MH, AlAmeel T, Beshir MA, Almadi MA, Al-Taweel T, Atkinson NS, Biswas S, Chapman T, Dulai PS, Glaire MA, Hoekman DR, et al. Placebo response and remission rates in randomised trials of induction and maintenance therapy for Crohn’s disease Cochrane Database of Systematic Reviews. 2016. DOI: 10.1002/14651858.Cd012288.Pub2 |
0.328 |
|
| 2016 |
Qiu SF, Lian H, Zou GY, Zeng XS. Interval estimation for a proportion using a double-sampling scheme with two fallible classifiers. Statistical Methods in Medical Research. PMID 27932666 DOI: 10.1177/0962280216681599 |
0.343 |
|
| 2016 |
Dubcenco E, Zou G, Stitt L, Baker JP, Jeejeebhoy KN, Kandel G, Kim YI, Grover SC, McDonald JW, Shackelton LM, Khanna R, D'Haens G, Sandborn WJ, Feagan BG, Levesque BG. Effect of Standardised Scoring Conventions on Inter-rater Reliability in the Endoscopic Evaluation of Crohn's Disease. Journal of Crohn's & Colitis. PMID 27385400 DOI: 10.1093/Ecco-Jcc/Jjw120 |
0.401 |
|
| 2016 |
Jairath V, Zou G, Parker CE, Macdonald JK, Mosli MH, Khanna R, Shackelton LM, Vandervoort MK, AlAmeel T, Al Beshir M, AlMadi M, Al-Taweel T, Atkinson NS, Biswas S, Chapman TP, et al. Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis. Journal of Crohn's & Colitis. PMID 26746169 DOI: 10.1093/Ecco-Jcc/Jjw004 |
0.317 |
|
| 2016 |
Dubcenco E, Zou G, Stitt L, Baker J, Jeejeebhoy K, Kandel G, Kim Y, Grover S, McDonald J, Shackelton L, Khanna R, DʼHaens G, Sandborn W, Vandervoort M, Feagan B, et al. P-026 Effect of Standardized Scoring Conventions on Inter-Rater Reliability in the Endoscopic Evaluation of Crohnʼs Disease Inflammatory Bowel Diseases. 22. DOI: 10.1097/01.Mib.0000480117.43672.38 |
0.365 |
|
| 2015 |
Mosli MH, Feagan BG, Zou G, Sandborn WJ, D'Haens G, Khanna R, Shackelton LM, Walker CW, Nelson S, Vandervoort MK, Frisbie V, Samaan MA, Jairath V, Driman DK, Geboes K, et al. Development and validation of a histological index for UC. Gut. PMID 26475633 DOI: 10.1136/Gutjnl-2015-310393 |
0.353 |
|
| 2015 |
Khanna R, Bressler B, Levesque BG, Zou G, Stitt LW, Greenberg GR, Panaccione R, Bitton A, Paré P, Vermeire S, D'Haens G, MacIntosh D, Sandborn WJ, Donner A, Vandervoort MK, et al. Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial. Lancet (London, England). PMID 26342731 DOI: 10.1016/S0140-6736(15)00068-9 |
0.548 |
|
| 2015 |
Mosli MH, Zou G, Garg SK, Feagan SG, MacDonald JK, Chande N, Sandborn WJ, Feagan BG. C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis. The American Journal of Gastroenterology. 110: 802-19; quiz 820. PMID 25964225 DOI: 10.1038/Ajg.2015.120 |
0.376 |
|
| 2015 |
Khanna R, Zou G, D'Haens G, Rutgeerts P, McDonald JW, Daperno M, Feagan BG, Sandborn WJ, Dubcenco E, Stitt L, Vandervoort MK, Donner A, Luo A, Levesque BG. Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease. Gut. PMID 25935574 DOI: 10.1136/Gutjnl-2014-308973 |
0.578 |
|
| 2015 |
Boland BS, Boyle DL, Sandborn WJ, Firestein GS, Levesque BG, Hillman J, Zhang B, Proudfoot J, Eckmann L, Ernst PB, Rivera-Nieves J, Pola S, Copur-Dahi N, Zou G, Chang JT. Validation of gene expression biomarker analysis for biopsy-based clinical trials in Crohn's disease. Inflammatory Bowel Diseases. 21: 323-30. PMID 25545378 DOI: 10.1097/Mib.0000000000000264 |
0.396 |
|
| 2015 |
Khanna R, Zou G, D'Haens G, Feagan BG, Sandborn WJ, Vandervoort MK, Rolleri RL, Bortey E, Paterson C, Forbes WP, Levesque BG. A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity. Alimentary Pharmacology & Therapeutics. 41: 77-86. PMID 25348809 DOI: 10.1111/Apt.13001 |
0.406 |
|
| 2015 |
Ordás I, Rimola J, Zou G, Santillan C, Horsthuis K, Taylor SA, Panes J, Khanna R, Stoker J, Stitt L, D'Haens GR, Sandborn W, Feagan BG, Vandervoort MK, Levesque BG. Tu1213 Reproducibility of Magnetic Resonance Enterography Assessment of Disease Activity in Crohn's Disease Using Central Readers Gastroenterology. 148: S-824. DOI: 10.1016/S0016-5085(15)32801-8 |
0.343 |
|
| 2015 |
Mosli MH, Zou G, Garg SK, Feagan S, MacDonald JK, Sandborn W, Chande N, Feagan BG. Su1094 A Systematic Review and Meta-Analysis of Non-Invasive Biomarkers for Assessing Disease Activity in Inflammatory Bowel Disease Gastroenterology. 148: S-406. DOI: 10.1016/S0016-5085(15)31366-4 |
0.359 |
|
| 2015 |
Jairath V, Parker CE, Zou G, MacDonald JK, AlAmeel T, Beshir MA, Almadi MA, Al-Taweel T, Atkinson N, Biswas S, Chapman T, Dulai P, Glaire MA, Hoekman DR, Koutsoumpas AL, et al. Su1062 Placebo Response and Remission Rates in Ulcerative Colitis Clinical Trials: Systematic Review and Meta-Analysis Gastroenterology. 148: S-396. DOI: 10.1016/S0016-5085(15)31334-2 |
0.311 |
|
| 2015 |
Dulai PS, Singh S, Cesarini M, Bouguen G, Nelson SA, Peyrin‐Biroulet L, Feagan BG, Ordas I, Sandborn WJ, Santillan C, Rimola J, Panes J, D'Haens G, Zou G, Stoker J, et al. MRI scoring indices for evaluation of disease activity and severity in Crohn’s disease Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.Cd011630 |
0.369 |
|
| 2014 |
Mosli MH, Feagan BG, Zou G, Sandborn WJ, D'Haens G, Khanna R, Behling C, Kaplan K, Driman DK, Shackelton LM, Baker KA, MacDonald JK, Vandervoort MK, Samaan MA, Geboes K, et al. Reproducibility of histological assessments of disease activity in UC. Gut. PMID 25360036 DOI: 10.1136/Gutjnl-2014-307536 |
0.36 |
|
| 2014 |
Poirier J, Zou G, Koval J. Confidence intervals for a difference between lognormal means in cluster randomization trials. Statistical Methods in Medical Research. PMID 25267552 DOI: 10.1177/0962280214552291 |
0.372 |
|
| 2014 |
Levesque BG, Greenberg GR, Zou G, Sandborn WJ, Singh S, Hauenstein S, Ohrmund L, Wong CJ, Stitt LW, Shackelton LM, King D, Lockton S, Ducharme J, Feagan BG. A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease. Alimentary Pharmacology & Therapeutics. 39: 1126-35. PMID 24689499 DOI: 10.1111/Apt.12733 |
0.375 |
|
| 2014 |
Feagan BG, McDonald JW, Panaccione R, Enns RA, Bernstein CN, Ponich TP, Bourdages R, Macintosh DG, Dallaire C, Cohen A, Fedorak RN, Paré P, Bitton A, Saibil F, Anderson F, ... ... Zou G, et al. Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease. Gastroenterology. 146: 681-688.e1. PMID 24269926 DOI: 10.1053/J.Gastro.2013.11.024 |
0.54 |
|
| 2014 |
Mosli M, Feagan B, Zou G, Geboes K, Langner C, Peterson M, Pai R, Sandborn W, D'Haens G, Vandervoort M, Behling C, Kaplan K, Shackelton L, Jones J, Khanna R, et al. P284 Agreement of central readers in the evaluation of histopathological disease activity in ulcerative colitis Journal of Crohn's and Colitis. 8: S181-S182. DOI: 10.1016/S1873-9946(14)60405-0 |
0.339 |
|
| 2014 |
Khanna R, D'Haens G, Feagan B, Sandborn W, Vandervoort M, Zou G, Rolleri R, Bortey E, Levesque B. P176 Patient reported outcome measures derived from the Crohn's Disease Activity Index: Correlation between PRO2 and PRO3 scores and CDAI-defined clinical thresholds Journal of Crohn's and Colitis. 8: S135-S136. DOI: 10.1016/S1873-9946(14)60297-X |
0.326 |
|
| 2014 |
Levesque B, Loftus E, Panaccione R, McDonald J, Van Assche G, Zou G, Stitt L, Khanna R, Sandborn W, D'Haens G, Vandervoort M, Feagan B. P150 Responsiveness of endoscopic indices in the evaluation of ulcerative colitis Journal of Crohn's and Colitis. 8: S124. DOI: 10.1016/S1873-9946(14)60272-5 |
0.305 |
|
| 2014 |
Khanna R, Zou G, D'Haens G, Rutgeerts P, McDonald J, Daperno M, Feagan B, Sandborn W, Dubcenco E, Vandervoort M, Luo A, Levesque B. OP024 Agreement among central readers in the evaluation of endoscopic disease activity in Crohn's disease Journal of Crohn's and Colitis. 8: S13-S14. DOI: 10.1016/S1873-9946(14)60025-8 |
0.349 |
|
| 2014 |
Khanna R, Levesque B, Bressler B, Zou G, Stitt L, Greenberg G, Panaccione R, Bitton A, Pare P, Vermeire S, D'Haens G, MacIntosh D, Sandborn W, Vandervoort M, Morris J, et al. OP004 Early combined immunosuppression for the management of Crohn's disease: A community-based cluster randomized trial Journal of Crohn's and Colitis. 8: S2-S3. DOI: 10.1016/S1873-9946(14)60005-2 |
0.367 |
|
| 2014 |
Khanna R, D'Haens GR, Feagan BG, Sandborn W, Vandervoort MK, Zou G, Rolleri RL, Paterson C, Forbes WP, Bortey E, Levesque BG. Sa1195 Patient Reported Outcome Measures Derived From the Crohn's Disease Activity Index: Correlation Between PRO2 and PRO3 Scores and CDAIDefined Clinical Thresholds Gastroenterology. 146: S-226. DOI: 10.1016/S0016-5085(14)60799-X |
0.382 |
|
| 2014 |
Mosli MH, Feagan BG, Zou G, Geboes K, Langner C, Peterson MR, Pai R, Sandborn W, D'Haens GR, Vandervoort MK, Behling C, Kaplan KJ, Shackelton LM, Jones J, Khanna R, et al. Sa1192 Agreement of Central Readers in the Evaluation of Histopathological Disease Activity in Ulcerative Colitis Gastroenterology. 146: S-225. DOI: 10.1016/S0016-5085(14)60796-4 |
0.355 |
|
| 2014 |
Khanna R, Levesque BG, Bressler B, Zou G, Stitt L, Greenberg GR, Panaccione R, Bitton A, Pare P, Vermeire S, D'Haens GR, MacIntosh DG, Sandborn W, Vandervoort MK, Morris JC, et al. 1053 Early Combined Immunosuppression for the Management of Crohn's Disease: A Community-Based Cluster Randomized Trial Gastroenterology. 146: S-187. DOI: 10.1016/S0016-5085(14)60664-8 |
0.352 |
|
| 2014 |
Khanna R, Zou G, D'Haens GR, Rutgeerts PJ, McDonald JW, Daperno M, Feagan BG, Sandborn W, Dubcenco E, Vandervoort MK, Luo A, Levesque BG. 1000 Agreement Among Central Readers in the Evaluation of Endoscopic Disease Activity in Crohn's Disease Gastroenterology. 146: S-175. DOI: 10.1016/S0016-5085(14)60619-3 |
0.388 |
|
| 2013 |
Feagan BG, Sandborn WJ, D'Haens G, Pola S, McDonald JW, Rutgeerts P, Munkholm P, Mittmann U, King D, Wong CJ, Zou G, Donner A, Shackelton LM, Gilgen D, Nelson S, et al. The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis. Gastroenterology. 145: 149-157.e2. PMID 23528626 DOI: 10.1053/J.Gastro.2013.03.025 |
0.572 |
|
| 2013 |
Zou GY, Donner A. Extension of the modified Poisson regression model to prospective studies with correlated binary data. Statistical Methods in Medical Research. 22: 661-70. PMID 22072596 DOI: 10.1177/0962280211427759 |
0.486 |
|
| 2013 |
Khanna R, DʼHaens G, Rutgeerts P, McDonald J, Daperno M, Feagan B, Sandborn W, Vandervoort M, Zou G, Levesque B. P-057 Reliability of Central Readers in the Evaluation of Endoscopic Disease Activity in Crohn’s Disease Inflammatory Bowel Diseases. 19: S50. DOI: 10.1097/01.Mib.0000438736.06039.04 |
0.366 |
|
| 2013 |
Levesque B, Pola S, King D, D'Haens GR, McDonald JW, Zou G, Sandborn W, Feagan BG. Tu1119 Responsiveness of Central Endoscopic Assessment of Disease Activity Using the Modified Mayo Clinic Score in Ulcerative Colitis Gastroenterology. 144: S-767. DOI: 10.1016/S0016-5085(13)62835-8 |
0.376 |
|
| 2013 |
Pola S, Feagan BG, Fahmy M, Vandervoort MK, D'Haens GR, McDonald JW, Panaccione R, Rutgeerts PJ, Travis S, Van Assche GA, Vermeire S, Loftus EV, Zou G, Nelson S, Sandborn W, et al. Tu1106 Observer Agreement and Construct Validity in Central Endoscopic Assessment of Disease Activity in Ulcerative Colitis Gastroenterology. 144: S-763. DOI: 10.1016/S0016-5085(13)62822-X |
0.405 |
|
| 2013 |
Pola S, Patel NS, Muralimohan R, Zou G, Santillan C, Levesque B, Sandborn W. Su1174 The Use of Magnetic Resonance Enterography for Diagnosis and Monitoring of Inflammatory Bowel Disease in Clinical Practice Gastroenterology. 144: S-419. DOI: 10.1016/S0016-5085(13)61541-3 |
0.321 |
|
| 2013 |
Mosli M, Fahmy M, Garg SK, Feagan SG, Baker KA, Zou G, MacDonald JK, Sandborn WJ, Chande N. Biomarkers for assessing disease activity in inflammatory bowel disease Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.Cd010848 |
0.35 |
|
| 2012 |
Donner A, Zou GY. Closed-form confidence intervals for functions of the normal mean and standard deviation. Statistical Methods in Medical Research. 21: 347-59. PMID 20826501 DOI: 10.1177/0962280210383082 |
0.52 |
|
| 2011 |
Donner A, Zou GY. Estimating simultaneous confidence intervals for multiple contrasts of proportions by the method of variance estimates recovery Statistics in Biopharmaceutical Research. 3: 320-335. DOI: 10.1198/Sbr.2010.09050 |
0.482 |
|
| 2010 |
Li Y, Koval JJ, Donner A, Zou GY. Interval estimation for the area under the receiver operating characteristic curve when data are subject to error. Statistics in Medicine. 29: 2521-31. PMID 20684006 DOI: 10.1002/Sim.4015 |
0.464 |
|
| 2010 |
Feagan BG, McDonald JW, Panaccione R, Enns RA, Bernstein CN, Ponich TP, Bourdages R, MacIntosh DG, Dallaire C, Cohen A, Fedorak RN, Pare P, Bitton A, Saibil F, Anderson F, ... ... Zou GY, et al. S1051 Methotrexate for the Prevention of Antibodies to Infliximab in Patients With Crohn's Disease Gastroenterology. 138: S-167-S-168. DOI: 10.1016/S0016-5085(10)60767-6 |
0.483 |
|
| 2009 |
Ramasundarahettige CF, Donner A, Zou GY. Confidence interval construction for a difference between two dependent intraclass correlation coefficients. Statistics in Medicine. 28: 1041-53. PMID 19142855 DOI: 10.1002/Sim.3523 |
0.491 |
|
| 2008 |
Feagan BG, Sandborn WJ, Mittmann U, Bar-Meir S, D'Haens G, Bradette M, Cohen A, Dallaire C, Ponich TP, McDonald JW, Hébuterne X, Paré P, Klvana P, Niv Y, Ardizzone S, ... ... Zou GY, et al. Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials. Jama. 299: 1690-7. PMID 18398081 DOI: 10.1001/Jama.299.14.1690 |
0.524 |
|
| 2008 |
Zou GY, Donner A. Construction of confidence limits about effect measures: a general approach. Statistics in Medicine. 27: 1693-702. PMID 17960596 DOI: 10.1002/Sim.3095 |
0.493 |
|
| 2008 |
Feagan B, McDonald JW, Panaccione R, Enns RA, Bernstein CN, Ponich TP, Bourdages R, MacIntosh DG, Dallaire C, Cohen A, Fedorak R, Pare P, Bitton A, Saibil F, Anderson F, ... ... Zou GY, et al. A Randomized Trial of Methotrexate in Combination With Infliximab for the Treatment of Crohn's Disease Gastroenterology. 135: 294-295. DOI: 10.1053/J.Gastro.2008.05.061 |
0.516 |
|
| 2007 |
Wong CJ, Vandervoort MK, Vandervoort SL, Donner A, Zou G, MacDonald JK, Freedman J, Karkouti K, MacDonald SJ, Feagan BG. A cluster-randomized controlled trial of a blood conservation algorithm in patients undergoing total hip joint arthroplasty. Transfusion. 47: 832-41. PMID 17465948 DOI: 10.1111/J.1537-2995.2007.01197.X |
0.501 |
|
| 2007 |
Donner A, Zou GY. Methods for the statistical analysis of binary data in split-mouth designs with baseline measurements. Statistics in Medicine. 26: 3476-86. PMID 17149800 DOI: 10.1002/Sim.2782 |
0.483 |
|
| 2007 |
Zou G, Donner A. The reply of Zou & Donner to Teo's commentary on their manuscript Annals of Human Genetics. 71: 704. DOI: 10.1111/J.1469-1809.2007.00357.X |
0.48 |
|
| 2006 |
Zou GY, Donner A. The merits of testing Hardy-Weinberg equilibrium in the analysis of unmatched case-control data: a cautionary note. Annals of Human Genetics. 70: 923-33. PMID 17044866 DOI: 10.1111/J.1469-1809.2006.00267.X |
0.459 |
|
| 2005 |
Zou GY, Donner A, Klar N. Group sequential methods for cluster randomization trials with binary outcomes. Clinical Trials (London, England). 2: 479-87. PMID 16422308 DOI: 10.1191/1740774505Cn126Oa |
0.487 |
|
| 2005 |
Zou G, Klar N. A non-iterative confidence interval estimating procedure for the intraclass kappa statistic with multinomial outcomes. Biometrical Journal. Biometrische Zeitschrift. 47: 682-90. PMID 16385909 DOI: 10.1002/Bimj.200310154 |
0.341 |
|
| 2005 |
Donner A, Hauck WW, Zou G. The impact of missing values in the concentration-time curve on the assessment of bioequivalence Pharmaceutical Statistics. 4: 91-99. DOI: 10.1002/Pst.156 |
0.504 |
|
| 2004 |
Donner A, Klar N, Zou G. Methods for the statistical analysis of binary data in split-cluster designs. Biometrics. 60: 919-25. PMID 15606412 DOI: 10.1111/J.0006-341X.2004.00247.X |
0.525 |
|
| 2004 |
Zou G, Donner A. Confidence interval estimation of the intraclass correlation coefficient for binary outcome data. Biometrics. 60: 807-11. PMID 15339305 DOI: 10.1111/J.0006-341X.2004.00232.X |
0.527 |
|
| 2004 |
Zou G. A modified poisson regression approach to prospective studies with binary data. American Journal of Epidemiology. 159: 702-6. PMID 15033648 DOI: 10.1093/Aje/Kwh090 |
0.33 |
|
| 2004 |
Zou G, Donner A. A simple alternative confidence interval for the difference between two proportions. Controlled Clinical Trials. 25: 3-12. PMID 14980745 DOI: 10.1016/J.Cct.2003.08.010 |
0.561 |
|
| 2002 |
Donner A, Zou G. Interval estimation for a difference between intraclass kappa statistics. Biometrics. 58: 209-15. PMID 11890316 DOI: 10.1111/J.0006-341X.2002.00209.X |
0.536 |
|
| 2002 |
Donner A, Zou G. Testing the equality of dependent intraclass correlation coefficients Journal of the Royal Statistical Society Series D: the Statistician. 51: 367-379. DOI: 10.1111/1467-9884.00324 |
0.502 |
|
| Show low-probability matches. |